PushUps4Parkinsons Competitors

Welcome to the United States Department of Veterans Affairs (VA) Official LinkedIn page. We're recruiting the finest employees to care for our #Veterans. Following/engagement ≠ signify VA endorsement. This is a moderated page, meaning that all comments will be reviewed for appropriate content. Please show respect to others. Comments that do not directly relate to the topics covered on this page, including commerce, external links, spam, abusive or vulgar language, hate speech, accusations against individuals, or personal attacks will be considered “off topic” and may not be posted. VA reserves the right to determine which comments are acceptable for this page. VA may remove comments that do not follow these terms, or comments that VA may reasonably believe could cause harm if they remain. VA may, at its sole discretion, terminate a user’s ability to post comments to this site for repeated or excessive violations of these standards. For more information, please visit bit.ly/2Q14Y1p

The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to help the approximately one million with PD in the United States live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $252 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against PD and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as our national Research Program and Centers for Advanced Research, please visit us at www.apdaparkinson.org.

The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.